Overview
CuraGen Biotech is on a mission to transform the treatment of rare genetic disorders through innovative, targeted therapies. We have successfully developed a proprietary platform that enables rapid identification and development of therapeutics tailored to specific genetic mutations. Over the past two years, we've progressed through preclinical studies with promising results, and our lead candidate is now ready for clinical trials. This next phase is critical, and we are seeking an investment of $1,500,000 to fund our clinical trials, expand our research team, and enhance our laboratory capabilities. We have worked diligently to establish a robust pipeline of therapies. Our focus on genetic disorders means tapping into a niche market with high unmet medical needs. Initial data from our preclinical studies indicate that our lead compound can effectively address these disorders, which has drawn interest from potential pharmaceutical partners. Our team has extensive experience in biotech and has successfully brought therapies from concept to market in the past. Despite achieving substantial progress, we require additional capital to navigate the complexities of clinical development an…
Use of funds
The $1,500,000 will be allocated as follows:
- Clinical trial costs: $800,000
- Research and development: $400,000
- Hiring key personnel: $200,000
- Operational costs including lab enhancements: $100,000
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.